Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127K Sell
59,393
-654
-1% -$1.64K 0.02% 314
2026
Q1
$128K Buy
60,047
+484
+0.8% +$940 0.03% 265
2025
Q4
$91.1K Sell
59,563
-315
-0.5% -$523 0.02% 244
2025
Q3
$88K Sell
59,878
-810
-1% -$1.2K 0.02% 212
2025
Q2
$108K Sell
60,688
-4,554
-7% -$6.75K 0.03% 197
2025
Q1
$95.3K Sell
65,242
-25
-0% -$49 0.04% 164
2024
Q4
$99.9K Hold
65,267
0.04% 148
2024
Q3
$97.2K Sell
65,267
-1,281
-2% -$2.34K 0.03% 156
2024
Q2
$123K Sell
66,548
-1,189
-2% -$2.48K 0.05% 143
2024
Q1
$136K Sell
67,737
-1,309
-2% -$3.05K 0.06% 127
2023
Q4
$157K Sell
69,046
-3,030
-4% -$2.65K 0.08% 113
2023
Q3
$38.2K Buy
72,076
+52,756
+273% +$58K 0.02% 107
2023
Q2
$22K Buy
19,320
+2,271
+13% +$1.98K 0.02% 89
2023
Q1
$12.6K Buy
+17,049
New +$14K 0.01% 82

Other funds holding CGEN

EWA LLC's CGEN Position: Q2 2026 in Review

EWA LLC reduced its Compugen (CGEN) stake by 1.1% in Q2 2026, selling an estimated $1.64K and leaving 59,393 shares worth $127K. The position accounts for 0.02% of the portfolio, ranked #314.

EWA LLC first reported a position in CGEN in Q1 2023 and has held it in 14 quarters since. The position peaked at $157K in Q4 2023. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

  • EWA LLC held 59,393 shares of Compugen worth $127K as of Q2 2026.
  • EWA LLC sold 654 Compugen shares in Q2 2026, an estimated $1.64K.
  • Compugen made up 0.02% of EWA LLC's portfolio in Q2 2026, its #314 holding.
  • EWA LLC first reported a position in Compugen in Q1 2023 and has held it in 14 quarters since.
  • EWA LLC's Compugen position peaked at $157K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.